WMSA
Weiss Multi-Strategy Advisers Portfolio holdings
AUM
$3.94B
1-Year Return
29.08%
This Quarter Return
+4.68%
1 Year Return
+29.08%
3 Year Return
+75.24%
5 Year Return
+223.81%
10 Year Return
+334.33%
AUM
$1.17B
AUM Growth
-$818M
(-41%)
Cap. Flow
-$922M
Cap. Flow
% of AUM
-78.53%
Top 10 Holdings %
Top 10 Hldgs %
20.03%
Holding
534
New
95
Increased
54
Reduced
194
Closed
147
Top Buys
| 1 |
PPS
Post Properties
PPS
|
$18.3M |
| 2 |
CSX Corp
CSX
|
$13.5M |
| 3 |
Acadia Realty Trust
AKR
|
$13.3M |
| 4 |
UDR
UDR
|
$12.9M |
| 5 |
XPO
XPO
|
$12.6M |
Top Sells
| 1 |
BDN
Brandywine Realty Trust
BDN
|
$51.9M |
| 2 |
Prologis
PLD
|
$44.2M |
| 3 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
$42.9M |
| 4 |
Douglas Emmett
DEI
|
$34.6M |
| 5 |
STOR
STORE Capital Corporation
STOR
|
$25.9M |
Sector Composition
| 1 | Real Estate | 26.85% |
| 2 | Industrials | 13.64% |
| 3 | Consumer Discretionary | 9.49% |
| 4 | Healthcare | 8.01% |
| 5 | Energy | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Molina Healthcare
MOH
$9.47B
| $206K | 0.02% |
4,130
-6,975
| -63% | -$348K |
|
|
SPNC
327
DELISTED
Spectranetics Corp
SPNC
| $205K | 0.02% |
10,935
-9,065
| -45% | -$170K |
|
328
Alnylam Pharmaceuticals
ALNY
$59.2B
| $202K | 0.02% |
3,645
-4,355
| -54% | -$241K |
|
329
Curis
CRIS
$21M
| $198K | 0.02% |
1,268
-862
| -40% | -$135K |
|
330
Standard BioTools
LAB
$497M
| $197K | 0.02% |
21,870
-18,130
| -45% | -$163K |
|
331
Xenon Pharmaceuticals
XENE
$3.02B
| $191K | 0.01% |
32,400
-18,600
| -36% | -$110K |
|
332
Sangamo Therapeutics
SGMO
$165M
| $190K | 0.01% |
+32,805
| New | +$190K |
|
|
ANTH
333
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $186K | 0.01% |
7,518
-5,107
| -40% | -$126K |
|
334
TG Therapeutics
TGTX
$5.11B
| $185K | 0.01% |
30,600
-20,400
| -40% | -$123K |
|
|
MACK
335
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $177K | 0.01% |
4,170
-2,821
| -40% | -$120K |
|
|
IMMU
336
DELISTED
Immunomedics Inc
IMMU
| $169K | 0.01% |
72,900
-7,100
| -9% | -$16.5K |
|
337
Traws Pharma
TRAW
$12.6M
| $154K | 0.01% |
5
| – | – |
|
|
NVDQ
338
DELISTED
Novadaq Technologies Inc.
NVDQ
| $143K | 0.01% |
14,580
-10,420
| -42% | -$102K |
|
339
Exelixis
EXEL
$10.2B
| $142K | 0.01% |
18,225
+8,225
| +82% | +$64.1K |
|
340
Exact Sciences
EXAS
$10.2B
| $134K | 0.01% |
+10,935
| New | +$134K |
|
341
Cytokinetics
CYTK
$6.34B
| $125K | 0.01% |
13,122
-8,878
| -40% | -$84.6K |
|
|
TTOO
342
DELISTED
T2 Biosystems, Inc
TTOO
| $115K | 0.01% |
3
-2
| -40% | -$76.7K |
|
|
ALIM
343
DELISTED
Alimera Sciences, Inc.
ALIM
| $108K | 0.01% |
5,832
-1,835
| -24% | -$34K |
|
344
Geron
GERN
$893M
| $55K | ﹤0.01% |
20,700
-14,300
| -41% | -$38K |
|
345
Catalyst Pharmaceutical
CPRX
$2.48B
| $49K | ﹤0.01% |
69,255
-52,745
| -43% | -$37.3K |
|
|
GOGL
346
DELISTED
Golden Ocean Group
GOGL
| $46K | ﹤0.01% |
13,789
-12,211
| -47% | -$40.7K |
|
|
ROKA
347
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
| $31K | ﹤0.01% |
5,468
-2,657
| -33% | -$15.1K |
|
348
Nuwellis
NUWE
$4.41M
| – | – |
0
| – | -$42K |
|
|
VIRX
349
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $12K | ﹤0.01% |
104
-86
| -45% | -$9.92K |
|
350
Citigroup
C
$176B
| – | – |
-250,326
| Closed | -$10.5M |
|